| Reference dose (RfD): description and use in health risk assessments DG Barnes, M Dourson, P Preuss, J Bellin, C Derosa, R Engler, ... Regulatory toxicology and pharmacology 8 (4), 471-486, 1988 | 733 | 1988 |
| Regulatory history and experimental support of uncertainty (safety) factors ML Dourson, JF Stara Regulatory toxicology and pharmacology 3 (3), 224-238, 1983 | 564 | 1983 |
| Copper and human health: biochemistry, genetics, and strategies for modeling dose-response relationships BR Stern, M Solioz, D Krewski, P Aggett, TC Aw, S Baker, K Crump, ... Journal of Toxicology and Environmental Health, Part B 10 (3), 157-222, 2007 | 420 | 2007 |
| Evolution of science-based uncertainty factors in noncancer risk assessment ML Dourson, SP Felter, D Robinson Regulatory Toxicology and Pharmacology 24 (2), 108-120, 1996 | 367 | 1996 |
| Differential sensitivity of children and adults to chemical toxicity: I. Biological basis R Scheuplein, G Charnley, M Dourson Regulatory Toxicology and Pharmacology 35 (3), 429-447, 2002 | 230 | 2002 |
| Mathematical modelling and quantitative methods L Edler, K Poirier, M Dourson, J Kleiner, B Mileson, H Nordmann, ... Food and Chemical Toxicology 40 (2-3), 283-326, 2002 | 174 | 2002 |
| Guidelines for the derivation of biomonitoring equivalents: report from the biomonitoring equivalents expert workshop SM Hays, LL Aylward, JS LaKind, MJ Bartels, HA Barton, PJ Boogaard, ... Regulatory Toxicology and Pharmacology 51 (3), S4-S15, 2008 | 172 | 2008 |
| Benchmark dose (BMD) modeling: current practice, issues, and challenges LT Haber, ML Dourson, BC Allen, RC Hertzberg, A Parker, MJ Vincent, ... Critical reviews in toxicology 48 (5), 387-415, 2018 | 171 | 2018 |
| Hazard identification and dose response of inhaled nickel-soluble salts LT Haber, L Erdreicht, GL Diamond, AM Maier, R Ratney, Q Zhao, ... Regulatory Toxicology and Pharmacology 31 (2), 210-230, 2000 | 147 | 2000 |
| The scientific basis of uncertainty factors used in setting occupational exposure limits DA Dankovic, BD Naumann, A Maier, ML Dourson, LS Levy Journal of occupational and environmental hygiene 12 (sup1), S55-S68, 2015 | 123 | 2015 |
| A probabilistic framework for the reference dose (probabilistic RfD) JC Swartout, PS Price, ML Dourson, HL Carlson‐Lynch, RE Keenan Risk Analysis 18 (3), 271-282, 1998 | 114 | 1998 |
| Differential sensitivity of children and adults to chemical toxicity: II. Risk and regulation M Dourson, G Charnley, R Scheuplein Regulatory Toxicology and Pharmacology 35 (3), 448-467, 2002 | 109 | 2002 |
| Application of the threshold of toxicological concern concept to pharmaceutical manufacturing operations DG Dolan, BD Naumann, EV Sargent, A Maier, M Dourson Regulatory Toxicology and Pharmacology 43 (1), 1-9, 2005 | 106 | 2005 |
| Methods for establishing oral reference doses (RfDs) ML Dourson Risk assessment of essential elements, 51-61, 1994 | 102 | 1994 |
| Guidelines for application of chemical-specific adjustment factors in dose/concentration–response assessment ME Meek, A Renwick, E Ohanian, M Dourson, B Lake, BD Naumann, ... Toxicology 181, 115-120, 2002 | 98* | 2002 |
| Novel methods for the estimation of acceptable daily intake ML Dourson, RC Hertzberg, R Hartung, K Blackburn Toxicology and Industrial Health 1 (4), 23-41, 1985 | 97 | 1985 |
| On reference dose (RfD) and its underlying toxicity data base ML Dourson, LA Knauf, JC Swartout Toxicology and Industrial Health 8 (3), 171-189, 1992 | 90 | 1992 |
| A reproductive, developmental and neurobehavioral study following oral exposure of tetrabromobisphenol A on Sprague-Dawley rats RB Cope, S Kacew, M Dourson Toxicology 329, 49-59, 2015 | 85 | 2015 |
| Guidelines for the communication of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop JS LaKind, LL Aylward, C Brunk, S DiZio, M Dourson, DA Goldstein, ... Regulatory Toxicology and Pharmacology 51 (3), S16-S26, 2008 | 83 | 2008 |
| Genetic polymorphisms in assessing interindividual variability in delivered dose LT Haber, A Maier, PR Gentry, HJ Clewell, ML Dourson Regulatory Toxicology and Pharmacology 35 (2), 177-197, 2002 | 79 | 2002 |
Paul S. PriceRisk Sciences InternationalVerified email at pipeline.com
